Rightslink® by Copyright Clearance Center

Impact de la période d’initiation et de la ligne de biothérapie sur le taux de rétention du secukinumab (SEC) dans la spondyloarthrite axiale (SpAax). Données de l’étude rétrospective multicentrique française FORSYA

Author:

M. Dougados,A. Lardy-Cléaud,E. Desfleurs,P. Claudepierre,P. Goupille,A. Ruyssen-Witrand,A. Saraux,A. Tournadre,D. Wendling,C. Lukas

Publication:

Revue du Rhumatisme

Publisher:

Elsevier

Date:

December 2023

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.